-

Hims & Hers Announces New Anti-Dandruff Shampoo for Hims Customers

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is today announcing Hims Dandruff Detox, a unique shampoo formulated with doctors that both fights dandruff and supports scalp health. This powerful and gently-cleansing formula was developed with doctors to be vegan, cruelty-free and free of parabens, phthalates, sulfates and dyes.

“Our Hims & Hers customers continue to demand more products that address hair health right at the source. Due to dandruff’s follicle-clogging impact and inflammation, dandruff and hair loss often go hand in hand – and with about half of people facing dandruff at some point in their life, we’re proud to serve customers with this addition to our portfolio,” said Dr. Pat Carroll, Chief Medical Officer at Hims & Hers. “We set out to create an effective dandruff shampoo that helps to remove flakes, itch and scalp irritation. By incorporating avocado oil to strengthen hair strands and a refreshing evergreen mint scent that doesn’t have a medicated fragrance, people can proudly display Dandruff Detox in their shower.”

The Dandruff Detox formula combines both zinc pyrithione, an ingredient that fights flakes and itch, and soothing Argan oil to help nourish the scalp. Starting today, this product is available for purchase through ForHims.com, as well as from a variety of retailers nationwide including CVS, Amazon, and Revolve.

The new shampoo expands on an existing line-up of the brand’s hair care products for men, including Thick Fix Shampoo and Conditioner, Max Volume Shampoo and Conditioner, Biotin Builder Gummies, Minoxidil Foam and Drops, as well as prescription offerings such as the 2-in-1 Finasteride, Minoxidil spray and oral Finasteride. Anyone interested in a prescription product is required to complete a free online consultation with a licensed healthcare provider through the Hims & Hers platform. The medical provider will determine if prescription treatment is appropriate.

For more information on Hims’ hair offerings, please visit https://www.forhims.com/hair-loss.

About Hims & Hers

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit https://investors.forhims.com/.

Hims & Hers Health, Inc.

NYSE:HIMS

Release Versions

More News From Hims & Hers Health, Inc.

Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the second quarter ended June 30, 2026. “Hims & Hers is delivering a world-class health experience at a global scale and a reasonable price for the nearly 3 million people who rely on us for access to care. We’re proving, quarter after quarter, that helping people feel great and delivering strong...

Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers, the leading health and wellness platform, today announced a first-of-its-kind* intelligent care experience that puts AI directly inside customers’ care, not on the sidelines of it. Rolling out first to Hers weight loss members, this proactive care experience delivers personalized guidance, real-time attention to her progress, and keeps her motivated so she can hit her goals. "Most AI in health sits outside your care. It can tell you things, but i...

Hims & Hers Responds to FTC Lawsuit

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims. This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense. We are co...
Back to Newsroom